WHAT: The 17th Annual San Antonio Express-News Book & Author Luncheon benefiting the Phase I Clinical Research Program of the Cancer Therapy & Research Center at the UT Health Science Center. More than $1.8 million has been raised over the fundraiser’s 16-year history.
Six authors with new books will speak at the luncheon:
Novel – Julia Glass, “I See You Everywhere”
Novel – Jon Katz, “Izzy & Lenore: Two Dogs, An Unexpected Journey, and Me”
Novel – David Liss, “The Whiskey Rebels”
Novel – Marisa de los Santos, “Belong to Me”
Cookbook – Steven Raichlen, “The Barbecue! Bible 10th Anniversary Edition”
Nonfiction – Margot Theis Raven, “Happy Birthday to You: How Two Kentucky
Kindergarten Teachers Wrote the Most Famous Song in the World”
WHEN: Thursday, October 30, 2008.
Book sales open at 10:00 a.m. Luncheon program, 11:30 a.m. – 1:00 p.m.
WHERE: Marriott Rivercenter Hotel, 101 Bowie Street
WHO: Ms. of Ceremonies, Dr. Coleen Grissom, Professor of English, Trinity University
Welcome: Dr. Francisco G. Cigarroa, President, UT Health Science Center at
San Antonio
Overview of Phase 1 Clinical Research Program: Dr. Francis J. Giles, Professor of
Medical Hematology and Medical Oncology, CTRC at the UT Health Science Center
NOTE TO MEDIA: If you would like to attend as our guest, please RSVP by Monday, Oct. 27.
The University of Texas Health Science Center at San Antonio is the leading research institution in South Texas and one of the major health sciences universities in the world. With an operating budget of $668 million, the Health Science Center is the chief catalyst for the $15.3 billion biosciences and health care sector in San Antonio’s economy. The Health Science Center has had an estimated $35 billion impact on the region since inception and has expanded to six campuses in San Antonio, Laredo, Harlingen and Edinburg. More than 23,000 graduates (physicians, dentists, nurses, scientists and other health professionals) serve in their fields, including many in Texas. Health Science Center faculty are international leaders in cancer, cardiovascular disease, diabetes, aging, stroke prevention, kidney disease, orthopaedics, research imaging, transplant surgery, psychiatry and clinical neurosciences, pain management, genetics, nursing, dentistry and many other fields. For more information, visit www.uthscsa.edu.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the nation’s leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of a few elite cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only three in Texas. CTRC handles more than 120,000 patient visits each year and is a world leader in developing new drugs to treat cancer. The CTRC Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug trials program in the world, and participated in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit our Web site at www.ctrc.uthscsa.edu.